Transcriptional profiling of Clostridium difficile and Caco-2 cells during infection

Journal of Infectious Diseases

Volumn 202, Issue 2, 2010, Pages 282-290

  Janvilisri, Tavan ^a,b   Scaria, Joy ^a   Chang, Yung Fu ^a  

^a Department of Obstetrics Gynecology   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTOME;

ARTICLE; CELL COMMUNICATION; CELL METABOLISM; CELL STRAIN CACO 2; CELL TRANSPORT; CELL VIABILITY; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; CELL SURVIVAL; COLON TUMOR; DNA MICROARRAY; GENETIC TRANSCRIPTION; GENETICS; IN SITU HYBRIDIZATION; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; PSEUDOMEMBRANOUS COLITIS;

CACO-2 CELLS; CELL SURVIVAL; CLOSTRIDIUM DIFFICILE; COLONIC NEOPLASMS; ENTEROCOLITIS, PSEUDOMEMBRANOUS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; IN SITU HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC;

EID: 77954608134     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/653484     Document Type: Article

References (36)

1. Kelly CP, LaMont JT. Clostridium difficile infection. Annu Rev Med 1998; 49:375-390.
2. Arroyo LG, Kruth SA, Willey BM, Staempfli HR, Low DE, Weese JS. PCR ribotyping of Clostridium difficile isolates originating fromhuman and animal sources. J Med Microbiol 2005; 54:163-166.
3. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005; 353: 2433-2441.
4. Chang JY, Antonopoulos DA, Kalra A, et al. Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis 2008; 197:435-438.
5. Jank T, Giesemann T, Aktories K. Rho-glycosylating Clostridium difficile toxins A and B: new insights into structure and function. Glycobiology 2007; 17:15R-22R. (Pubitemid 46432006)
6. Voth DE, Ballard JD. Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 2005; 18:247-263.
7. Perelle S, Gibert M, Bourlioux P, Corthier G, Popoff MR. Production of a complete binary toxin (actin-specific ADP-ribosyltransferase) by Clostridium difficile CD196. Infect Immun 1997; 65:1402-1407.
8. Barth H, Aktories K, Popoff MR, Stiles BG. Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins. Microbiol Mol Biol Rev 2004; 68:373-402.
9. Geric B, Carman RJ, Rupnik M, et al. Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters J Infect Dis 2006; 193:1143-1150.
10. Geric B, Rupnik M, Gerding DN, Grabnar M, Johnson S. Distribution of Clostridium difficile variant toxinotypes and strains with binary toxin genes among clinical isolates in an American hospital. J Med Microbiol 2004; 53:887-894.
11. Lyras D, O'Connor JR, Howarth PM, et al. Toxin B is essential for virulence of Clostridium difficile. Nature 2009; 458:1176-1179.
12. Drudy D, Fanning S, Kyne L. Toxin A-negative, toxin B-positive Clostridium difficile. Int J Infect Dis 2007; 11:5-10.
13. Denève C, Janoir C, Poilane I, Fantinato C, Collignon A. New trends in Clostridium difficile virulence and pathogenesis. Int J Antimicrob Agents 2009; 33:S24-S28.
14. Pituch, H. Clostridium difficile is no longer just a nosocomial infection or an infection of adults Int J Antimicrob Agents 2009; 33:S42-S45.
15. Janvilisri T, Scaria J, Thompson AD, et al. Microarray identification of Clostridium difficile core components and divergent regions associated with host origin. J Bacteriol 2009; 191:3881-3891.
16. Emerson JE, Stabler RA,Wren BW, Fairweather NF.Microarray analysis of the transcriptional responses of Clostridium difficile to environmental and antibiotic stress. J Med Microbiol 2008; 57:757-764.
17. Gerhard R, Tatge H, Genth H, et al. Clostridium difficile toxin A induces expression of the stress-induced early gene product RhoB. J Biol Chem 2005; 280:1499-1505.
18. Janvilisri T, Scaria J, Gleed R, et al. Development of a microarray for identification of pathogenic Clostridium spp. Diag Microb Infect Dis 2010; 66:140-147.
19. Scaria, J, Palaniappan RU, Chiu D, et al. Microarray for molecular typing of Salmonella enterica serovars. Mol Cell Probes 2008; 22:238-243.
20. Saeed AI, Sharov V, White J, et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003; 34: 374-378.
21. Jensen LJ, Kuhn M, Stark M, et al. STRING 8-a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res 2009; 37:D412-D416.
22. Poncet S, Milohanic E, Mazé A, et al. Correlations between carbon metabolism and virulence in bacteria. Contrib Microbiol 2009; 16:88-102.
23. Karlsson S, Burman LG, Akerlund T. Induction of toxins in Clostridium difficile is associated with dramatic changes of its metabolism. Microbiology 2008; 154:3430-3436.
24. Sonenshein, AL. CodY, a global regulator of stationary phase and virulence in Gram-positive bacteria. Curr Opin Microbiol 2005; 8:203-207.
25. Dineen SS, Villapakkam AC, Nordman JT, Sonenshein AL. Repression of Clostridium difficile toxin gene expression by CodY. Mol Microbiol 2007; 66:206-219.
26. Pothoulakis C. Effects of Clostridium difficile toxins on epithelial cell barrier. Ann N Y Acad Sci 2000; 915:347-356.
27. Popoff MR, Geny B. Multifaceted role of Rho, Rac, Cdc42 and Ras in intercellular junctions, lessons from toxins. Biochim Biophys Acta 2009; 1788:797-812.
28. González-Mariscal L, Tapia R, Chamorro D. Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta 2008; 1788: 729-756.
29. Janoir C, Péchiné S, Grosdidier C, Collignon A. Cwp84, a surfaceassociated protein of Clostridium difficile, is a cysteine protease with degrading activity on extracellular matrix proteins. J Bacteriol 2007; 189:7174-7180.
30. Green LJ, Mould AP, Humphries MJ. The integrin beta subunit. Int J Biochem Cell Biol 1998; 30:179-184.
31. Meylan E, Martinon F, Thome M, Gschwendt M, Tschopp J. RIP4 (DIK/PKK), a novel member of the RIP kinase family, activates NFkappa B and is processed during apoptosis. EMBO Rep 2002; 3:1201-1208.
32. Fukao T, Koyasu S. PI3K and negative regulation of TLR signaling. Trends Immunol 2003; 24:358-363.
33. Ling P, Lu TJ, Yuan CJ, Lai MD. Biosignaling of mammalian Ste20- related kinases. Cell Signal 2008; 20:1237-1247.
34. Nakayama K, Hatakeyama S, Maruyama S, et al. Impaired degradation of inhibitory subunit of NF-kappa B (I kappa B) and beta-catenin as a result of targeted disruption of the beta-TrCP1 gene. Proc Natl Acad Sci U S A 2003; 100:8752-8757.
35. Kawai T, Akira S. Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med 2007; 13:460-469.
36. Nauseef, WM. How human neutrophils kill and degrade microbes: an integrated view. Immunol Rev 2007; 219:88-102.